These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33358753)

  • 1. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement.
    Brandon C; Oh C; Brucker BM; Rosenblum N; Ferrante KL; Smilen SW; Nitti VW; Pape DM
    Urology; 2021 Feb; 148():93-99. PubMed ID: 33358753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy.
    Pincus J; Rostaminia G; Chang C; Gafni-Kane A; Goldberg RP
    Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world Compliance With Percutaneous Tibial Nerve Stimulation Maintenance Therapy in an American Population.
    Du C; Berg W; Siegal AR; Huang Z; Jeong R; Hwang K; Kim J
    Urology; 2021 Jul; 153():119-123. PubMed ID: 33581232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome.
    Rostaminia G; Chang C; Pincus JB; Sand PK; Goldberg RP
    Int Urogynecol J; 2019 Oct; 30(10):1735-1745. PubMed ID: 30498931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Long-Term Use of Percutaneous Tibial Nerve Stimulation for Management of Overactive Bladder Syndrome.
    Gordon T; Merchant M; Ramm O; Patel M
    Female Pelvic Med Reconstr Surg; 2021 Jul; 27(7):444-449. PubMed ID: 32649325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
    Kapur A; Aalami Harandi A; Hartman-Kenzler J; Kim J
    Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder.
    Iyer S; Laus K; Rugino A; Botros C; Lozo S; Botros SM; Goldberg R; Tomezsko J; Gafni-Kane A; Wroblewski K; Sand P
    Int Urogynecol J; 2019 Aug; 30(8):1253-1259. PubMed ID: 30467763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial.
    Kopcsay KS; Marczak TD; Jeppson PC; Cameron AP; Khavari R; Tefera E; Gutman RE
    Int Urogynecol J; 2022 Apr; 33(4):851-860. PubMed ID: 34993598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience.
    Andersen K; Kobberø H; Pedersen TB; Poulsen MH
    Scand J Urol; 2021 Apr; 55(2):169-176. PubMed ID: 33635171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients.
    Te Dorsthorst MJ; Heesakkers JPFA; van Balken MR
    Neurourol Urodyn; 2020 Feb; 39(2):702-706. PubMed ID: 31845404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Tibial Nerve Stimulation in the Office Setting: Real-world Experience of Over 100 Patients.
    Sirls ER; Killinger KA; Boura JA; Peters KM
    Urology; 2018 Mar; 113():34-39. PubMed ID: 29196071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
    Musco S; Serati M; Lombardi G; Lumi E; Parisi AI; Del Popolo G; Finazzi Agrò E
    J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
    Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM; Eltabey NA; Wadie BS
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.